Workflow
SNIBE(300832)
icon
Search documents
7月批准注册医械产品295个;适龄女生可免费接种HPV疫苗
Policy Developments - The National Healthcare Security Administration issued the "Guidelines for the Establishment of Pricing Projects for Physical Therapy Medical Services (Trial)" which integrates existing pricing projects into 32 items, with 7 additional charges and 1 expansion item [2] Medical Device Approvals - In July, the National Medical Products Administration approved 295 medical device products, including 240 domestic Class III devices, 21 imported Class III devices, 29 imported Class II devices, and 5 devices from Hong Kong, Macau, and Taiwan [4] Company Announcements - New Industries announced that 18 of its chemiluminescent reagent products received IVDR CE certification, allowing them to enter the EU market, which is expected to enhance the company's competitiveness [5] - Jining Pharmaceutical received a drug re-registration approval for hydrolyzed protein injection, which is used for severe amino acid deficiency and will help restore normal production and sales [6] - Chongqing Pharmaceutical Holdings reported a net profit of 282 million yuan for the first half of the year, with a revenue of 41.188 billion yuan, marking a 3.54% year-on-year increase [8] - Jimin Health reported a net loss of 52.6959 million yuan for the first half of 2025, with a revenue of 36.6 million yuan, down 21.30% year-on-year [9] - Chenguang Bio announced plans to transfer 97.5% of its subsidiary Chenguang Tianrun Pharmaceutical to Sichuan Tongsheng Biomedical, with the transfer based on the subsidiary's equity as of July 31, 2025 [11] - Baiyang Pharmaceutical's controlling shareholder plans to increase capital and change the shareholding structure, with a new entity set to acquire 80% of the controlling group [13] Industry Events - A groundbreaking cervical spine surgery was successfully performed in Shanghai, utilizing innovative "satellite steel plate" technology to stabilize a severely injured patient's spine [15] - Guangxi plans to provide free HPV vaccinations to nearly 960,000 eligible girls from 2025 to 2027, emphasizing the importance of preventive healthcare [16] Shareholder Actions - Multiple shareholders of Sanxin Medical plan to reduce their stakes in the company due to personal financial needs, with specific share amounts outlined for each individual [18]
新产业股价上涨1.86% 18项试剂获欧盟IVDR认证
Jin Rong Jie· 2025-08-20 16:32
新产业最新股价报60.29元,较前一交易日上涨1.86%。盘中最高触及60.45元,最低下探58.60元,成交 金额达2.61亿元。 新产业主要从事体外诊断产品的研发、生产和销售。公司产品涵盖化学发光免疫分析仪器及配套试剂、 生化分析仪器及配套试剂等。2025年一季度,公司实现营业收入11.25亿元,净利润4.38亿元。 公司公告显示,近日18项化学发光试剂产品获得欧盟IVDR CE认证,有效期至2025年12月14日。截至目 前,公司累计获得211项化学发光试剂和67项生化试剂的IVDR CE认证。 8月20日主力资金净流入187.81万元,近五日主力资金净流出6897.22万元。 风险提示:市场有风险,投资需谨慎。 ...
郭元强赴洪山区武昌区调研并召开座谈会:高质量推进城市更新产业升级 加快推动中心城区转型发展
Chang Jiang Ri Bao· 2025-08-20 14:04
来到位于洪山区的青菱都市工业园,郭元强调研传统工业园区转型发展情况,走进园区 企业筑梦科技公司,察看AI机器人及数字化产品展示。他希望园区聚焦智能制造、数字经 济等新兴产业领域,提升服务保障水平,增强对技术、人才、资金等创新要素的吸引力,着 力培育引进科技型企业,推动园区高质量发展。来到武昌区的数字经济标杆楼宇武汉数创大 厦,郭元强详细了解楼宇招商、运行情况,走进入驻企业保伦电子股份有限公司进行调研。 他勉励数创大厦要优化服务、创新管理,持续营造良好创新生态,吸引更多优质企业入驻, 为中心城区产业转型探索有益经验。 8月20日,省委常委、市委书记郭元强赴洪山区、武昌区调研都市工业园区、数字经济 楼宇,并召开座谈会专题研究中心城区转型发展。他强调,要深入学习贯彻中央城市工作会 议精神和习近平总书记考察湖北重要讲话精神,坚持把创新作为第一动力,以推进城市更新 为重要抓手,深化数智赋能产业升级,促进数字经济与先进制造业、现代服务业深度融合, 加快推动中心城区转型发展,不断塑造发展新动能新优势。 座谈会上,郭元强听取相关情况汇报,与都市工业园区、创新楼宇及产业协会代表深入 交流。他指出,中心城区是高端要素资源的重要集 ...
新产业(300832) - 关于公司产品获得IVDR CE认证的公告
2025-08-20 09:52
证券代码:300832 证券简称:新产业 公告编号:2025-062 深圳市新产业生物医学工程股份有限公司 关于公司产品获得 IVDR CE 认证的公告 根据欧盟体外诊断医疗器械法规的规定,本次获得IVDR CE认证的产品已经 具备进入欧盟市场的必要条件,后续将进一步增强公司产品的综合竞争力,对公 司未来的经营将产生积极影响。上述产品实际销售情况取决于未来市场推广效果, 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 近日,深圳市新产业生物医学工程股份有限公司(以下简称"公司")18 项化学发光试剂产品获得了由欧盟公告机构-TÜV南德意志集团签发的IVDR CE 认证。具体获证情况如下: | 序 号 | 产品名称 | 有效期 | | | | | 证书编号 | | 临床用途 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | Influenza A Virus IgM (CLIA) 有 甲型流行性感冒病毒IgM抗体检测试剂盒 | 效 | 期 | 至 | No. | | V12 ...
新产业收盘上涨1.86%,滚动市盈率25.75倍,总市值473.71亿元
Sou Hu Cai Jing· 2025-08-20 09:51
Group 1 - The core viewpoint of the articles highlights the performance and market position of Shenzhen New Industry Biomedical Engineering Co., Ltd. in the medical device sector, particularly in the in vitro diagnostics field [1] - As of August 20, the company's stock closed at 60.29 yuan, with a PE ratio of 25.75, marking a 49-day low, and a total market capitalization of 47.371 billion yuan [1] - The average PE ratio for the medical device industry is 59.32, with a median of 39.97, placing the company at 49th in industry rankings [1][2] Group 2 - The company reported a revenue of 1.125 billion yuan for Q1 2025, reflecting a year-on-year increase of 10.12%, and a net profit of 438 million yuan, up 2.65% year-on-year, with a gross margin of 68.01% [1] - A total of 48 institutions hold shares in the company, with a combined holding of 33.4155 million shares valued at 1.895 billion yuan [1] - The company has received accolades such as the "National Brand Gold Award" for medical equipment in 2024, indicating high customer satisfaction and service quality, particularly in tertiary hospitals [1]
猴痘概念下跌0.86%,主力资金净流出61股
Market Performance - The monkeypox concept sector declined by 0.86%, ranking among the top losers in the market, with stocks like Fuyuan Pharmaceutical and Chengyi Pharmaceutical hitting the daily limit down [1] - Notable declines were observed in Wanfu Biology, Rejing Biology, and Zhongsheng Pharmaceutical, while 23 stocks within the sector saw price increases, with Toukeng Life, Chuangyuan Technology, and New Industry leading the gains at 7.45%, 3.96%, and 1.86% respectively [1][2] Capital Flow - The monkeypox concept sector experienced a net outflow of 1.624 billion yuan, with 61 stocks facing net outflows, and 11 stocks seeing outflows exceeding 50 million yuan [2] - The stock with the highest net outflow was Hanyu Pharmaceutical, with a net outflow of 212.3 million yuan, followed by Fuyuan Pharmaceutical, Wanfu Biology, and Zhongsheng Pharmaceutical with net outflows of 164.1 million yuan, 126 million yuan, and 120 million yuan respectively [2][3] Top Gainers and Losers - The top gainers in the monkeypox concept sector included Toukeng Life, which saw a net inflow of 24.68 million yuan, and Guoyao Modern with a net inflow of 2.185 million yuan [4] - Conversely, the top losers included Hanyu Pharmaceutical, Fuyuan Pharmaceutical, and Wanfu Biology, which all faced significant capital outflows [2][3]
南宁高新产业建设开发集团有限公司主体等级获“AA+”评级
Sou Hu Cai Jing· 2025-08-20 04:25
资料显示,公司由南宁高新区管委会于1992年4月出资成立,2021年9月由全民所有制企业改制为有限责 任公司(国有独资),公司名称由"南宁新技术产业建设开发总公司"变更为现名,并相应修改公司章 程,注册资本由29.80亿元变更为39.00亿元。2021年10月和2023年7月,南宁高新区管委会分别向公司增 资1.00亿元和2.00亿元。公司主要负责南宁高新区内工业标准厂房、总部基地办公楼和园区配套设施的 开发建设以及园区资产的经营管理等。随着高新区基础设施开发日益成熟,为适应南宁市"一体两翼"产 业发展新格局以及高新区优化升级阶段的发展需求,公司的职能定位由"南宁高新区内主要的园区开发 和国有资产经营主体"升级为南宁高新区的"高新产业综合服务商",围绕"建、管、投、融、服"五位一 体发展模式,构建产业载体开发、金融服务、产业投资、运营服务"四大板块",职能重要性进一步凸 显。公司当前收入主要来源园区资产的运营及管理,以及围绕园区项目业主开展的钢材、机械设备等的 贸易,和工程及附加业务等业务。2022~2024年及2025年1~3月,公司分别实现营业总收入21.64亿元、 21.91亿元、24.20亿元和4.4 ...
战新产业带动增强 机械工业经济效益回稳向好
Core Viewpoint - The mechanical industry in China has shown stable growth in the first half of 2025, with key economic indicators performing well, but it still faces significant challenges from external uncertainties and domestic demand pressures [1][2][12]. Economic Performance - The mechanical industry achieved a value-added growth of 9.0% in the first half of 2025, outperforming the national industrial and manufacturing growth rates by 2.6 and 2 percentage points respectively [3]. - The number of enterprises above designated size in the mechanical industry reached 136,000, an increase of 6,000 year-on-year, accounting for 26.2% of the national industrial total [2]. - Total assets in the mechanical industry amounted to 40.4 trillion yuan, a year-on-year increase of 6.6% [2]. Production and Sales - The production and sales of mechanical products showed steady improvement, with 68.9% of 122 monitored products experiencing year-on-year production growth [3]. - Key sectors such as automotive and electrical machinery saw double-digit growth rates of 11.3% and 12.2% respectively [3]. Investment Trends - Fixed asset investment in the mechanical industry grew by 3.8% year-on-year, which is higher than the national investment growth rate of 2.8% but lower than the industrial average of 10.3% [4]. - Investment in general equipment and automotive sectors grew significantly by 16.6% and 22.2%, serving as the main drivers of investment growth [4]. Economic Efficiency - The mechanical industry generated operating revenue of 15.3 trillion yuan, a year-on-year increase of 7.8%, and total profits reached 791.2 billion yuan, up 9.4% [4]. - The profit margin for the industry was 5.2%, slightly above the national average [4]. Market Sentiment - The mechanical industry’s prosperity index was recorded at 106.9 in June, indicating a stable and improving economic environment [5]. - Five out of six sub-indices were above the critical value, reflecting positive production and industry development trends [5][6]. Challenges and Risks - The industry faces external challenges such as geopolitical tensions and trade uncertainties, which have led to cautious ordering behavior from foreign buyers [13][14]. - Domestic demand remains weak, with 66% of enterprises reporting insufficient orders, and the manufacturing PMI has been below the critical value for four consecutive months [14][11]. - The industry is also grappling with persistent price declines, with the machinery product price index showing a continuous decrease for 29 months [15]. Emerging Trends - The new energy and high-end equipment manufacturing sectors are driving growth, with revenues and profits in these areas significantly outpacing the overall mechanical industry [7]. - The market for new energy vehicles has seen rapid growth, with production and sales reaching 6.968 million and 6.937 million units respectively, marking year-on-year increases of 41.4% and 40.3% [8]. - The mechanical industry’s foreign trade remained resilient, with total trade volume reaching 597.6 billion USD, a year-on-year increase of 7.1% [8][9].
南宁高新产业建设开发集团有限公司307200000元24南宁高新CP001将兑付
Sou Hu Cai Jing· 2025-08-19 14:01
来源:金融界 2025年8月19日,上海清算所网站披露公告,为保证南宁高新产业建设开发集团有限公司2024年度第一 期短期融资券(债务融资工具简称:24南宁高新CP001,债务融资工具代码:042480433)兑付工作的 顺利进行,公告相关事宜。本期债券发行金额为人民币3亿元,起息日为2024年8月27日,发行期限1 年,债项余额为人民币3亿元,最新评级主体评级AA+,本计息期债项利率2.4%,本息兑付日为2025年 8月27日,本期应偿付本息金额为人民币307200000元。托管在银行间市场清算所股份有限公司的债券, 其兑付资金由发行人在规定时间之前划付至指定账户后,由该清算所在兑付日划付至债券持有人指定银 行账户,若遇法定节假日则划付资金时间顺延 ,债券持有人资金汇划路径变更应及时通知。此外无其 他需说明事项,发行人及相关方承诺公告内容真实、准确、完整、及时,并履行后续信息披露义务。 ...
年中观察:上海崛起虹梅漕河泾元宇宙街区新产业
Di Yi Cai Jing· 2025-08-19 03:07
2025年8月18日下午,上海徐汇区三季度稳增长专题调度会议举行。中共徐汇区委书记曹立强,区委副 书记、区长王华出席会议并讲话。会上徐汇区发改委汇报1-7月经济运行分析和三季度调度工作建议, 徐汇区政府领导郑长林、罗华品、邓大伟、魏兰、陈勇和相关部门分别发言。笔者注意到:曹立强强 调"要想尽一切办法,拿出超常规的力度,确保完成增长目标;要落实用好国家和市级政策工具,密切 跟踪后续政策动向,切实发挥撬动作用"。 在此之前的7月30日,上海市徐汇区第十七届人民代表大会第八次会议在西岸国际会展中心举行。区委 副书记、区长王华代表区人民政府报告2025年上半年工作情况;会议由区人大常委会主任李新华主持。 王华在政府工作报告中指出,今年是"十四五"规划收官之年,在市委、市政府和区委的坚强领导下,区 政府坚持稳中求进工作总基调,进一步推进"建设新徐汇、奋进新征程"各项目标任务,基本实现"时间 过半、完成任务过半"。笔者尤其注意到的是:王华区长强调——徐汇区政府总结好以大模型产业生态 体系孵化人工智能产业等成功经验,进一步完善顶层设计、深化实践探索,举全区之力向全国人工智能 高地迈进,为上海深化国际科技创新中心建设贡献徐汇 ...